1 Sabattini E, "WHO classification of tumours of haematopoietic and lymphoid tissues in 2008 : an overview" 102 : 83-87, 2010
2 Pishko A, "The role of novel immunotherapies in non-Hodgkin lymphoma" 6 : 93-103, 2017
3 Burkhardt B, "The impact of age and gender on biology, clinical features and treatment outcome of non-Hodgkin lymphoma in childhood and adolescence" 131 : 39-49, 2005
4 Topp MS, "Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia : a multicentre, single-arm, phase 2 study" 16 : 57-66, 2015
5 Patte C, "Results of the randomized international FAB/LMB96trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescents : it is possible to reduce treatment for the early responding patients" 109 : 2773-2780, 2007
6 Cairo MS, "Results of a randomized international study of high-risk central nervous system B non-Hodgkin lymphoma and B acute lymphoblastic leukemia in children and adolescents" 109 : 2736-2743, 2007
7 Mitsui T, "Recent progress in the treatment of pediatric lymphoma in Japan" 58 : 2168-2177, 2017
8 Le Deley MC, "Prognostic factors in childhood anaplastic large cell lymphoma : results of a large European intergroup study" 111 : 1560-1566, 2008
9 Burkhardt B, "Poor outcome for children and adolescents with progressive disease or relapse of lymphoblastic lymphoma : a report from the berlin-frankfurt-muenster group" 27 : 3363-3369, 2009
10 Batlevi CL, "Novel immunotherapies in lymphoid malignancies" 13 : 25-40, 2016
1 Sabattini E, "WHO classification of tumours of haematopoietic and lymphoid tissues in 2008 : an overview" 102 : 83-87, 2010
2 Pishko A, "The role of novel immunotherapies in non-Hodgkin lymphoma" 6 : 93-103, 2017
3 Burkhardt B, "The impact of age and gender on biology, clinical features and treatment outcome of non-Hodgkin lymphoma in childhood and adolescence" 131 : 39-49, 2005
4 Topp MS, "Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia : a multicentre, single-arm, phase 2 study" 16 : 57-66, 2015
5 Patte C, "Results of the randomized international FAB/LMB96trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescents : it is possible to reduce treatment for the early responding patients" 109 : 2773-2780, 2007
6 Cairo MS, "Results of a randomized international study of high-risk central nervous system B non-Hodgkin lymphoma and B acute lymphoblastic leukemia in children and adolescents" 109 : 2736-2743, 2007
7 Mitsui T, "Recent progress in the treatment of pediatric lymphoma in Japan" 58 : 2168-2177, 2017
8 Le Deley MC, "Prognostic factors in childhood anaplastic large cell lymphoma : results of a large European intergroup study" 111 : 1560-1566, 2008
9 Burkhardt B, "Poor outcome for children and adolescents with progressive disease or relapse of lymphoblastic lymphoma : a report from the berlin-frankfurt-muenster group" 27 : 3363-3369, 2009
10 Batlevi CL, "Novel immunotherapies in lymphoid malignancies" 13 : 25-40, 2016
11 Kontny U, "Non-anaplastic peripheral T-cell lymphoma in children and adolescents : a retrospective analysis of the NHL-BFM study group" 168 : 835-844, 2015
12 Reiter A, "Non-Hodgkin's lymphomas of childhood and adolescence : results of a treatment stratified for biologic subtypes and stage : a report of the Berlin-Frankfurt-Munster Group" 13 : 359-372, 1995
13 Minard-Colin V, "Non-Hodgkin lymphoma in children and adolescents : progress through effective collaboration, current knowledge, and challenges ahead" 33 : 2963-2974, 2015
14 Mussolin L, "Minimal disseminated disease in high-risk Burkitt's lymphoma identifies patients with different prognosis" 29 : 1779-1784, 2011
15 Coustan-Smith E, "Minimal disseminated disease in childhood T-cell lymphoblastic lymphoma : a report from the children's oncology group" 27 : 3533-3539, 2009
16 Shiramizu B, "Minimal disease assessment in the treatment of children and adolescents with intermediate-risk(Stage III/IV)B-cell non-Hodgkin lymphoma : a children's oncology group report" 153 : 758-763, 2011
17 Cairo MS, "Long-term follow-up of short intensive multiagent chemotherapy without high-dose methotrexate('Orange')in children with advanced non-lymphoblastic non-Hodgkin's lymphoma : a children's cancer group report" 16 : 594-600, 2002
18 Vose J, "International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes" 26 : 4124-4130, 2008
19 Marky I, "Intensive chemotherapy without radiotherapy gives more than 85% event-free survival for non-Hodgkin lymphoma without central nervous involvement : a 6-year population-based study from the nordic society of pediatric hematology and oncology" 26 : 555-560, 2004
20 Reiter A, "Intensive ALL-type therapy without local radiotherapy provides a 90% event-free survival for children with T-cell lymphoblastic lymphoma : a BFM group report" 95 : 416-421, 2000
21 Reiter A, "Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy : a report of the Berlin-Frankfurt-Munster Group Trial NHLBFM 90" 94 : 3294-3306, 1999
22 Anderson JR, "Epidemiology of the non-Hodgkin's lymphomas: distributions of the major subtypes differ by geographic locations. Non-Hodgkin's Lymphoma Classification Project" 9 : 717-720, 1998
23 Hwang IG, "Clinicopathologic features and treatment outcomes in malignant lymphoma of pediatric and young adult patients in Korea : comparison of Korean all-ages group and Western younger age group" 7 : 580-586, 2007
24 김혜리, "Clinical Outcome of Relapsed or Refractory Burkitt Lymphoma and Mature B-Cell Lymphoblastic Leukemia in Children and Adolescents" 대한암학회 46 (46): 358-365, 2014
25 Murphy SB, "Classification, staging and end results of treatment of childhood non-Hodgkin's lymphomas : dissimilarities from lymphomas in adults" 7 : 332-339, 1980
26 Brugieres L, "CD30(+)anaplastic large-cell lymphoma in children : analysis of 82 patients enrolled in two consecutive studies of the French Society of Pediatric Oncology" 92 : 3591-3598, 1998
27 Williams DM, "Anaplastic large cell lymphoma in childhood : analysis of 72 patients treated on the United Kingdom Children's Cancer Study Group chemotherapy regimens" 117 : 812-820, 2002
28 Cairo MS, "Advanced stage, increased lactate dehydrogenase, and primary site, but not adolescent age(≥15 years), are associated with an increased risk of treatment failure in children and adolescents with mature B-cell non-Hodgkin's lymphoma : results of the FAB LMB 96 study" 30 : 387-393, 2012
29 Hochberg J, "Adolescent non-Hodgkin lymphoma and Hodgkin lymphoma : state of the science" 144 : 24-40, 2009
30 Lymphoma Study Group, Subspecialty Group of Hematology, the Society of Pediatrics, Chinese Medical Association, "A collaborative study of children with lymphoblastic non-Hodgkin's lymphoma in China" 53 : 931-937, 2015